1.
Tsuzuki S, Yasuda T, Goto H, Maeda N, Akahane K, Inukai T, Yamamoto H, Karnan S, Ota A, Hyodo T, Konishi H, Hosokawa Y, Kiyoi H, Hayakawa F. BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia. haematol [Internet]. 2023Feb.1 [cited 2026Aug.28];108(2):394-08. Available from: https://haematologica.org/article/view/haematol.2022.280879